Dr. Ali Chamseddine

Dr. Ali Chamseddine is a French Board–Certified Consultant Medical Oncologist and Clinical Hematologist with over 15 years of experience in comprehensive cancer care and international training in France and the United States. He holds a PhD in Public Health and Molecular Oncology from the University of Paris-Saclay (summa cum laude) and has made significant contributions to clinical research, including novel methodologies in advanced gastric cancer and over 45 peer-reviewed publications, including in The New England Journal of Medicine. He trained at leading institutions such as Gustave Roussy Cancer Center and MD Anderson Cancer Center, and has held senior consultant and leadership roles in major oncology centers across France and the UAE. In Dubai, he was the founding Head of Oncology at Dr. Sulaiman Al Habib Hospital and currently practices at Al Zahra Hospital Dubai, delivering state-of-the-art, multidisciplinary cancer care. Dr. Chamseddine specializes in precision oncology, treating a broad spectrum of solid tumors and hematologic malignancies, with particular expertise in gastrointestinal, breast, lung, genitourinary, gynecologic cancers, lymphomas, and multiple myeloma, integrating molecular profiling and personalized therapies into care plans. Fluent in French, English, and Arabic, he is an active member of major international oncology societies and is widely recognized for his compassionate, evidence-based, and individualized approach to cancer treatment.